Objective: To study whether major weight loss causes sustained improvement in blood lipids and haemostatic pro®le in obese subjects, and to compare the in¯uence of two different slimming and maintenance regimens. Design: Two-stranded randomized intervention study. Setting: University Department. Subjects: Thirty-six out of 43 obese patients recruited from out-patient waiting list completed the study. Interventions: Weight loss was achieved by very low energy formula diet (2 MJad for 8 weeks, n 18), or lowenergy conventional diet (5 MJad for 17 weeks, n 18), both combined with anorectic compound. Participants were re-randomized to consume low fat diet ad libitum (n 16), or energy-restricted diet (n 20) for weight maintenance during 24 weeks. Main outcome measures: Plasma lipids, ®brinogen, factor VII coagulant activity (FVIIc), and plasminogen activator inhibitor type 1 (PAI-1) antigen. Results: Weight loss averaged 13.6 kg (95% CI: 12.3 ± 14.9 kg). After 24 weeks' weight maintenance, plasma total cholesterol was 9% lower, high density lipoprotein cholesterol 5% higher, triglycerides 30% lower, FVIIc 12% lower, ®brinogen 6% lower, and PAI-1 antigen 34% lower than at baseline (all changes highly signi®cant). There were no signi®cant differences between slimming or maintenance regimens. Conclusions: Major weight loss is associated with sustained and marked improvements in blood lipids and hemostatic pro®le, irrespective of the tested slimming and maintenance regimens.
Introduction
Obese individuals of both sexes have an increased risk of coronary heart disease (CHD) (Rimm et al, 1995; Manson et al, 1995) . This may be explained by unfavourable plasma lipid pro®les, blood hypercoagulability and impaired endogenous ®brinolysis (Mead et al, 1979; Terry et al, 1989; Folsom et al, 1991; Iso et al, 1993; Sundell et al, 1993) . Several earlier trials demonstrated that these abnormalities are corrected with weight reduction as assessed from measurements made during or shortly after slimming (Leenen et al, 1993; Andersen et al, 1995; Huisveld et al, 1990; Mehrabian et al, 1990; Slabber et al, 1992; Peternel et al, 1994; Palareti et al, 1994; Velthuiste Wierik et al, 1995; Calles-Escandon et al, 1996) . These studies cannot tell whether the bene®cial biochemical effects are primarily explained by the negative energy balance during slimming, or by the reduced body weight. Only few studies included measurements during the maintenance phase following weight loss (Leenen et al, 1993; Ogston & McAndrew, 1964; Baron et al, 1989; Phinney et al, 1991; Wing & Jeffery, 1995; Svendsen et al, 1996) . Our knowledge about the late impact of weight reduction on blood lipids and the haemostatic system is therefore limited. Some studies indicate that initial improvements may be lost during weight maintenance (Ogston & Andrew, 1964; Baron et al, 1989; Phinney et al, 1991; Svendsen et al, 1996) . In this report, we present blood lipid and haemostatic pro®les of obese individuals prior to a major weight loss and after 24 weeks of weight maintenance. Our ®ndings indicate that the biochemical pro®le is markedly and permanently improved and, accordingly, that the longterm risk of atherothrombotic disease is strongly reduced if body weight regain is prevented.
Methods
The study included 43 healthy obese individuals, but due to drop outs and missed blood samplings at follow-up only 36 individuals (34 females, 2 males) were available for the present analysis. The average participant was 44 y old (range 28 ±62 y). The average body weight was 98.0 kg (74.9 ± 121.6 kg), and average body mass index (BMI) 35.5 kgam 2 (28.9 ± 41.7) at baseline. None were taking any pharmaceutical compounds. All patients gave informed consent prior to study participation according to the Helsinki II declaration. The protocol was approved by the Municipal Ethical Committee of Copenhagen and Frederiksberg.
Design
At study entry, patients were randomized to either an 8 week very low energy formula diet (slimming powder, 2 MJad, Bli-Let, Nycomed DAK AaS, Roskilde, Denmark) (n 18) or a 17 week low energy conventional diet (5 MJad) (n 18), both supported by an anorectic compound (ephedrine 20 mg and caffeine 200 mg thrice daily, Let-igen, Nycomed DAK AaS, Roskilde, Denmark). After having passed the initial slimming phase of the study protocol, the anorectic compound was discontinued and patients rerandomized to one of two regimens for weight maintenance: either a low-fat high-carbohydrate diet to be consumed ad libitum (n 16), or an energy restricted diet based on calorie counting (n 20). Both groups were independently supervised by a dietician who saw the participants on average every second week for the following 52 weeks. The present study is based on blood samples collected before slimming and after 24 weeks of weight maintenance. There were no samples available for haemostatic measurements from the end of the slimming phase. Blood lipid data from the total study period were presented but have never been discussed before (Toubro & Astrup, 1997) .
Blood samplings
Blood for lipid analyses was sampled in EDTA tubes, for factor VII (FVII) and ®brinogen in citrated tubes, and for plasminogen activator inhibitor type I (PAI-1) in chilled acidi®ed Stabilyte tubes (Biopool, Umea Ê, Sweden). Plasma was separated at 3000 g for 15 min at 20 C or 4 C (PAI-1), and immediately stored at 780 C. Analyses were performed in one series for each participant within less than 12 months.
Blood analysis
Plasma total cholesterol, HDL cholesterol, and triglyceride concentrations were determined by enzymatic methods (Boehringer Mannheim GmbH, Mannheim, Germany). HDL cholesterol was estimated after precipitation of apoB-lipoproteins with phosphortungstic acid-MgCl 2 . Plasma FVII coagulant activity (FVIIc) was measured in a one-stage clotting assay using FVII-de®cient plasma (Biopool, Umea Ê, Sweden) and human brain tissue factor (Bladbjerg et al, 1994) . Plasma ®brinogen concentrations were assessed by a modi®ed Clauss assay (Jespersen & Sidelmann, 1982) . Plasma PAI-1 antigen concentrations were determined by a commercially available ELISA assay (Biopool, Umea Ê, Sweden). Body composition was estimated by the bioimpedance method with an Animeter (HTS-Engineering, Odense, Denmark), and fat free mass and fat mass were calculated from published equations (Heitmann, 1990) .
Dietary records
Participants were asked to make 7 d weighed food records after 24 weeks of weight maintenance. Records were obtained from 29 individuals, 12 from the ad libitum group and 17 from the restriction diet group. All records were coded and processed by the same experienced dietician. A computerised version of the Danish Nutrient Database was used to calculate the energy content and nutrient composition of the diets (Mùller, 1989) .
Statistics
Results are expressed as means and standard errors of the mean. Changes from baseline to follow-up were compared with paired, and differences between groups with unpaired t-tests. The impact of slimming and weight maintenance regimens on outcome was tested with an analysis of variance. A P-value below 0.05 was considered signi®cant.
Results
Body weight at baseline, immediately after weight loss, and at the end of the 24 week weight maintenance period are shown in Table 1 .
Both groups experienced major weight reductions during slimming, whereas body weights changed insigni®cantly during the following 24 weeks of maintenance. There were no signi®cant differences between slimming or maintenance regimens. Average BMI (n 36) was 35.5 before weight reduction and 30.3 kgam 2 after 24 weeks of maintenance. As reported earlier, some weight regain was observed later in the study, less with the ad libitum diet than with the energyrestricted diet (Toubro & Astrup, 1997) . Table 2 presents baseline and follow-up results on blood lipids, FVIIc, ®brinogen, and PAI-1 antigen. All variables were favourably affected with no signi®cant differences between the low fat diet and the restriction diet. On average, total cholesterol was 9% lower, HDL-cholesterol 5% higher, triglycerides 30% lower, FVIIc 12% lower, ®brinogen 6% lower, and PAI-1 antigen 34% lower at the end of the maintenance period relative to baseline. Similar results were obtained after exclusion of data from the two male participants, except for HDL-cholesterol. Without the males, the HDL-cholesterol increase was only borderline signi®cant (P 0.052).
In simple bivariate correlation analyses (n 36), body weight changes were signi®cantly associated with changes in plasma ®brinogen (r 0.48, P`0.01), but not with other biochemical variables. This correlation was explained by a highly signi®cant association between changes in fat mass and ®brinogen (r 0.53, P`0.001). A strong association between changes in waist circumference and ®brinogen (r 0.53), and a less prominent one between waistahip ratio and ®brinogen (r 0.40, P`0.01) were also demonstrated. There were no correlation between fat-free mass and ®brinogen changes. We observed no other associations between changes in fat mass or fat distribution as assessed from waist and hip circumferences and biochemical variables, including PAI-1 antigen.
Signi®cant associations were noted between changes in FVIIc and total cholesterol (r 0.41, P`0.01), PAI-1 and total cholesterol (r 0.39, P`0.01), triglycerides and total cholesterol (r 0.53, P`0.001), PAI-1 and triglycerides (r 0.40, P`0.01), and HDL-cholesterol and triglycerides (r 70.43, P`0.01). 
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The average dietary nutrient composition after 24 weeks of weight maintenance according to maintenance regimen is shown in Table 3 . There were no signi®cant group differences.
Discussion
Our volunteers, primarily females, had an initial average BMI of 35.5 kgam 2 . It declined to approximately 30 kgam 2 during slimming and remained there for the following 24 weeks. The associated plasma lipid changes aloneÐ the 9% (0.48 mmolaL) fall in total cholesterol, the concomitant 5% rise in HDL-cholesterol, and the 30% fall in triglycerides Ð indicate that the risk of future CHD death was reduced by 30% (Wald & Law, 1995) . The bene®cial haemostatic effects suggest an additional decline in CHD risk. From a baseline level almost twice that of healthy middle-aged non-obese individuals, FVIIc was lowered 12%, corresponding to an estimated 10 ±20% risk reduction (Meade et al, 1986) . Plasma ®brinogen declined by 6% which might lower the risk of future CHD another 10% (Meade et al, 1986; Meade et al, 1993) . We would expect that the 34% lowering of PAI-1, the main inhibitor of endogenous ®brinolysis, also would contribute (Gram et al, 1987; Hamsten et al, 1987) . Baseline values were about three times elevated compared with healthy non-obese subjects (Marckmann et al, 1992 . Overall, the estimated decline in relative CHD risk attributable to the combined effect of improved plasma lipid and haemostatic pro®les could easily approach 50%. This estimate is larger than estimates calculated on the basis of epidemiological studies. In one large American observational cohort study, women with BMI around 30 kgam 2 had a relative risk (RR) of CHD death that was only 20% lower than that of women with BMI of around 35 kgam 2 (Manson et al, 1995) . Another epidemiological study suggested that an intentional weight loss of 9.1 kg was associated with a 25% reduction in cardiovascular mortality (Williamson et al, 1995) . The true CHD risk reduction caused by the average 13.6 kg weight loss of our volunteers might lie somewhere between 20 and 50%.
The large majority of earlier trials looked at CHD risk factor changes during or shortly after weight loss. Most reports concluded that a weight loss of 5 ±15 kg is associated with a 10 ± 20% lowering of total cholesterol and a 20 ±30% lowering of triglycerides (Mehrabian et al, 1990; Folsom et al, 1993; Leenen et al, 1993; Palareti et al, 1994; Andersen et al, 1995; Calles-Escandon et al, 1996) . Observations on the immediate effect of weight loss on HDLcholesterol are more inconsistent (Leenen et al, 1993; Mehrabian et al, 1990; Palareti et al, 1994) . However, two studies indicated that HDL-cholesterol may increase above pre-slimming levels during weight maintenance (Phinney et al, 1991; Wing et al, 1995) . Our ®ndings underscore that the lowering of total cholesterol and triglycerides seen with weight reduction can be maintained in the long term, and furthermore con®rm that the late effect on HDL-cholesterol is favorable, namely that HDL-choles- Body weight reduction and CHD risk P Marckmann et al terol increases. Our study does not tell whether the plasma lipid changes were caused by the weight loss alone, or whether changes in the dietary nutrient composition were in¯uential. Earlier trials reached con¯icting conclusions on this issue and it needs to be investigated in more detail (Leenen et al, 1993; Andersen et al, 1995) . Obese individuals experience a 20±30% decline in FVIIc and a 40±60% decline in PAI concentrations when they are on very low calorie diets (Huisveld et al, 1990; Slabber et al, 1992; Palareti et al, 1994) . More moderate energy restriction is also associated with marked reductions in FVIIc and PAI-1 (Mehrabian et al, 1990; Folsom et al, 1993; Calles-Escandon et al, 1996) . Three studies suggested that these anti-thrombotic effects disappear during subsequent weight maintenance (Ogston & McAndrew, 1964; Svendsen et al, 1996; Baron et al, 1989) . These conclusions contrast with our ®ndings. One report was based on observations of only one subject, however (Ogston & McAndrew, 1964) . In the study of Svendsen et al, participants were in fact regaining weight (2 kg) during follow-up which might explain the ®nding that the initial pro®brinolytic effects disappeared (Svendsen et al, 1996) . The study by Baron et al was characterised by study participants that were only slightly overweight and who experienced only minor weight losses (3±4 kg) (Baron et al, 1989) . In our opinion, the present study strongly suggests that the marked antithrombotic and pro®brinolytic effects observed during periods of negative energy balance are not lost during subsequent weight maintenance. It is remarkable that our subjects also experienced a 6% decline in plasma ®brinogen. Mehrabian et al found a similar borderline signi®cant trend, but several others saw no immediate effect of weight loss on ®brinogen (Mehrabian et al, 1990; Palareti et al, 1994; Svendsen et al, 1996) . We believe that we can exclude that our ®nding was due to seasonal variation. Baseline samples were collected in August 1992 and follow-up samples in April±June 1993. According to the report by Woodhouse et al, this sampling pattern would not bias our results in the observed direction (Woodhouse et al, 1994) . No other studies reported the late effect of weight loss on ®brinogen, so our ®nding needs to be con®rmed in future studies. Our correlation analyses suggested that fat mass was an important determinant of the changes in ®brinogen. We were, however, unable to demonstrate a speci®c impact of fat mass, fat free mass and body fat distribution on other biochemical variables, including PAI-1 antigen concentrations. The association between central obesity and PAI-1 levels reported in some earlier reports thus could not be con®rmed (Landin et al, 1990; Mykka Ènen et al, 1994) .
Conclusion
Our results indicate that obese individuals experience a substantial and sustained cardiovascular risk reduction with 12± 15 kg slimming.
